Abstract
Osteoarthritis (OA) leads to significant pain and disability. For pain relief, a tailored approach using non-pharmacological and pharmacological therapies is recommended. If adequate symptom relief is not achieved with acetaminophen, other pharmacological options include non-steroidal anti-inflammatory drugs (NSAIDs), topical analgesics, intra-articular corticosteroids and intra-articular hyaluronic acid (HA) viscosupplementation. Most of these therapies generally do not improve functional ability or quality of life or are associated with tolerability concerns. In OA patients, concentration and molecular weight (MW) of HA are reduced, diminishing elastoviscosity of the synovial fluid, joint lubrication and shock absorbancy, and possibly anti-inflammatory, analgesic and chondroprotective effects. In knee OA, viscosupplementation with 3–5 weekly intra-articular HA injections diminishes pain and improves disability, generally within 1 week and for up to 3–6 months and is well tolerated. HAs have comparable efficacy as NSAIDs, with less gastrointestinal adverse events, and compared with intra-articular corticosteroids, benefits last generally longer. High MW hylans provide comparable benefits versus HA, albeit with an increased risk of immunogenic adverse events. In mild-to-moderate hip OA, intra-articular injection of HA moderately improved pain and function, generally for up to 3 months with no serious adverse events. Efficacy in other joints is being evaluated. Viscosupplementation with intra-articular Sinovial® (other trade names: Yaral®, Intragel®) injections (an HA of low-medium MW) relieves pain and improves function in OA of the knee, and other joints including the carpometacarpal joint of the thumb and the shoulder. HA viscosupplementation, including use of Sinovial®, is a valuable treatment approach for OA patients, if other therapies are contraindicated or have failed.
Similar content being viewed by others
References
National Institute for Clinical Excellence (2009) OSTEOARTHRITIS National clinical guideline for care and management in adults. Cited 4 Sept 2009. Available from: http://www.nice.org.uk/nicemedia/pdf/CG059FullGuideline.pdf
European Commission (2009) Indicators for monitoring Musculoskeletal Conditions Project. Cited 3 Sept 2009. Available from: http://ec.europa.eu/health/ph_information/dissemination/diseases/musculo_en.htm
World Health Organization (2003) The burden of musculoskeletal conditions at the start of the new millennium. WHO Technical Report Series 919. Cited 4 Sept 2009. Available from: http://whqlibdoc.who.int/trs/WHO_TRS_919.pdf
Hochberg MC (2000) Role of intra-articular hyaluronic acid preparations in medical management of osteoarthritis of the knee. Semin Arthr Rheum 30(2 Suppl 1):2–10
Strauss EJ, Hart JA, Miller MD, Altman RD, Rosen JE (2009) Hyaluronic acid viscosupplementation and osteoarthritis: current uses and future directions. Am J Sports Med 37(8):1636–1644
Altman RD (1990) Osteoarthritis. Differentiation from rheumatoid arthritis, causes of pain, treatment. Postgrad Med 87(3):66–72 7-8
Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JW, Dieppe P et al (2003) EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 62(12):1145–1155
Zhang W, Doherty M, Arden N, Bannwarth B, Bijlsma J, Gunther KP et al (2005) EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 64(5):669–681
Balazs EA, Denlinger JL (1993) Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol Suppl 39:3–9
Dahl LB, Dahl IM, Engstrom-Laurent A, Granath K (1985) Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis 44(12):817–822
Balazs E (ed) (1982) The physical properties of synovial fluid and the specific role of hyaluronic acid
Castellacci E, Polieri T (2004) Antalgic effect and clinical tolerability of hyaluronic acid in patients with degenerative diseases of knee cartilage: an outpatient treatment survey. Drugs Exp Clin Res 30(2):67–73
Moreland LW (2003) Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action. Arthr Res Ther 5(2):54–67
Vitanzo PC Jr, Sennett BJ (2006) Hyaluronans: is clinical effectiveness dependent on molecular weight? Am J Orthop 35(9):421–428
Dixon AS, Jacoby RK, Berry H, Hamilton EB (1988) Clinical trial of intra-articular injection of sodium hyaluronate in patients with osteoarthritis of the knee. Curr Med Res Opin 11(4):205–213
Maheu E, Ayral X, Dougados M (2002) A hyaluronan preparation (500–730 kDa) in the treatment of osteoarthritis: a review of clinical trials with Hyalgan. Int J Clin Pract 56(10):804–813
Hamburger MI, Lakhanpal S, Mooar PA, Oster D (2003) Intra-articular hyaluronans: a review of product-specific safety profiles. Semin Arthr Rheum 32(5):296–309
Brzusek D, Petron D (2008) Treating knee osteoarthritis with intra-articular hyaluronans. Curr Med Res Opin 24(12):3307–3322
Migliore A, Granata M (2008) Intra-articular use of hyaluronic acid in the treatment of osteoarthritis. Clin Interv Aging 3(2):365–369
ACR (2000) Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthr Rheum 43(9):1905–1915
Roddy E, Doherty M (2003) Guidelines for management of osteoarthritis published by the American College of Rheumatology and the European League Against Rheumatism: why are they so different? Rheum Dis Clin North Am 29(4):717–731
Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G (2006) Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2:CD005321
IBSA (2009) Sinovial®: summary of product characteristics
Theiler R, Bruhlmann P (2005) Overall tolerability and analgesic activity of intra-articular sodium hyaluronate in the treatment of knee osteoarthritis. Curr Med Res Opin 21(11):1727–1733
Roux C, Fontas E, Breuil V, Brocq O, Albert C, Euller-Ziegler L (2007) Injection of intra-articular sodium hyaluronidate (Sinovial) into the carpometacarpal joint of the thumb (CMC1) in osteoarthritis. A prospective evaluation of efficacy. Joint Bone Spine 74(4):368–372
Gomis A, Pawlak M, Balazs EA, Schmidt RF, Belmonte C (2004) Effects of different molecular weight elastoviscous hyaluronan solutions on articular nociceptive afferents. Arthr Rheum 50(1):314–326
Weiss C, Band PA (1999) Basic principles underlying the development of viscosupplementation for the treatment of osteoarthritis. J Clin Rheumatol 3:S2–S11
Lo GH, LaValley M, McAlindon T, Felson DT (2003) Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis. JAMA 290(23):3115–3121
Wobig M, Bach G, Beks P, Dickhut A, Runzheimer J, Schwieger G et al (1999) The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of hylan G-F 20 and a lower-molecular-weight hyaluronan. Clin Ther 21(9):1549–1562
Ghosh P, Guidolin D (2002) Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: are the effects molecular weight dependent? Semin Arthr Rheum 32(1):10–37
Reichenbach S, Blank S, Rutjes AW, Shang A, King EA, Dieppe PA et al (2007) Hylan versus hyaluronic acid for osteoarthritis of the knee: a systematic review and meta-analysis. Arthr Rheum 57(8):1410–1418
Onel E, Kolsun K, Kauffman JI (2008) Post-Hoc analysis of a head-to-head hyaluronic acid comparison in knee osteoarthritis using the 2004 OMERACT-OARSI responder criteria. Clin Drug Investig 28(1):37–45
Kotevoglu N, Iyibozkurt PC, Hiz O, Toktas H, Kuran B (2006) A prospective randomised controlled clinical trial comparing the efficacy of different molecular weight hyaluronan solutions in the treatment of knee osteoarthritis. Rheumatol Int 26(4):325–330
Brun P, Panfilo S, Daga Gordini D, Cortivo R, Abatangelo G (2003) The effect of hyaluronan on CD44-mediated survival of normal and hydroxyl radical-damaged chondrocytes. Osteoarthr Cartil 11(3):208–216
Wang CT, Lin YT, Chiang BL, Lin YH, Hou SM (2006) High molecular weight hyaluronic acid down-regulates the gene expression of osteoarthritis-associated cytokines and enzymes in fibroblast-like synoviocytes from patients with early osteoarthritis. Osteoarthr Cartil 14(12):1237–1247
Chou CL, Li HW, Lee SH, Tsai KL, Ling HY (2008) Effect of intra-articular injection of hyaluronic acid in rheumatoid arthritis patients with knee osteoarthritis. J Chin Med Assoc 71(8):411–415
Leopold SS, Warme WJ, Pettis PD, Shott S (2002) Increased frequency of acute local reaction to intra-articular hylan GF-20 (synvisc) in patients receiving more than one course of treatment. J Bone Joint Surg Am 84-A(9):1619–1623
Pullman-Mooar S, Mooar P, Sieck M, Clayburne G, Schumacher HR (2002) Are there distinctive inflammatory flares after hylan g-f 20 intraarticular injections? J Rheumatol 29(12):2611–2614
Goldberg VM, Coutts RD (2004) Pseudoseptic reactions to hylan viscosupplementation: diagnosis and treatment. Clin Orthop Relat Res 419:130–137
Carrabba M, Paresce E, Angelini M et al (1995) The safety and efficacy of different dose schedules of hyaluronic acid in the treatment of painful osteoarthritis of the knee with joint effusion. Eur J Rheumatol Inflamm 15:25–31
Dougados M, Nguyen M, Listrat V, Amor B (1993) High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. Osteoarthr Cartil 1(2):97–103
Listrat V, Ayral X, Patarnello F, Bonvarlet JP, Simonnet J, Amor B et al (1997) Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan) in osteoarthritis of the knee. Osteoarthr Cartil 5(3):153–160
Novaes AC, Schaiquevich P, Nasswetter G (2005) Multicenter study of hyaluronic acid obtained by biotechnology to evaluate clinical efficacy and safety in knee osteoarthritis. Int J Clin Pharmacol Res 25(1):1–7
Petrella RJ (2005) Hyaluronic acid for the treatment of knee osteoarthritis: long-term outcomes from a naturalistic primary care experience. Am J Phys Med Rehabil 84(4):278–283 quiz 84, 93
Altman RD, Moskowitz R (1998) Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group. J Rheumatol 25(11):2203–2212
Jones AC, Pattrick M, Doherty S, Doherty M (1995) Intra-articular hyaluronic acid compared to intra-articular triamcinolone hexacetonide in inflammatory knee osteoarthritis. Osteoarthr Cartil 3(4):269–273
Wobig M, Dickhut A, Maier R, Vetter G (1998) Viscosupplementation with hylan G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee. Clin Ther 20(3):410–423
Adams ME, Atkinson MH, Lussier AJ, Schulz JI, Siminovitch KA, Wade JP et al (1995) The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthr Cartil 3(4):213–225
Dickson DJ, Hosie G, English JR et al (2001) A double-blind, placebo-controlled comparison of hylan G-F 20 against diclofenac in knee osteoarthritis. J Drug Assess 4:179–190
Leopold SS, Redd BB, Warme WJ, Wehrle PA, Pettis PD, Shott S (2003) Corticosteroid compared with hyaluronic acid injections for the treatment of osteoarthritis of the knee. A prospective, randomized trial. J Bone Joint Surg Am 85-A(7):1197–1203
Karatosun V, Unver B, Gocen Z, Sen A (2005) Comparison of two hyaluronan drugs in patients with advanced osteoarthritis of the knee. A prospective, randomized, double-blind study with long term follow-up. Clin Exp Rheumatol 23(2):213–218
Karlsson J, Sjogren LS, Lohmander LS (2002) Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre study. Rheumatology 41(11):1240–1248
Pourbagher MA, Ozalay M, Pourbagher A (2005) Accuracy and outcome of sonographically guided intra-articular sodium hyaluronate injections in patients with osteoarthritis of the hip. J Ultrasound Med 24(10):1391–1395
Abate M, Pelotti P, De Amicis D, Di Iorio A, Galletti S, Salini V (2008) Viscosupplementation with hyaluronic acid in hip osteoarthritis (a review). Ups J Med Sci 113(3):261–277
Fernandez Lopez JC, Ruano-Ravina A (2006) Efficacy and safety of intraarticular hyaluronic acid in the treatment of hip osteoarthritis: a systematic review. Osteoarthr Cartil 14(12):1306–1311
Gaston MS, Tiemessen CH, Philips JE (2007) Intra-articular hip viscosupplementation with synthetic hyaluronic acid for osteoarthritis: efficacy, safety and relation to pre-injection radiographs. Arch Orthop Trauma Surg 127(10):899–903
Migliore A, Tormenta S, Massafra U, Martin Martin LS, Carloni E, Padalino C et al (2006) 18-month observational study on efficacy of intraarticular hyaluronic acid (Hylan G-F 20) injections under ultrasound guidance in hip osteoarthritis. Reumatismo 58(1):39–49
Berg P, Olsson U (2004) Intra-articular injection of non-animal stabilised hyaluronic acid (NASHA) for osteoarthritis of the hip: a pilot study. Clin Exp Rheumatol 22(3):300–306
Qvistgaard E, Christensen R, Torp-Pedersen S, Bliddal H (2006) Intra-articular treatment of hip osteoarthritis: a randomized trial of hyaluronic acid, corticosteroid, and isotonic saline. Osteoarthr Cartil 14(2):163–170
Conrozier T, Couris CM, Mathieu P, Merle-Vincent F, Piperno M, Coury F et al (2009) Safety, efficacy and predictive factors of efficacy of a single intra-articular injection of non-animal-stabilized-hyaluronic-acid in the hip joint: results of a standardized follow-up of patients treated for hip osteoarthritis in daily practice. Arch Orthop Trauma Surg 129(6):843–848
Richette P, Ravaud P, Conrozier T, Euller-Ziegler L, Mazieres B, Maugars Y et al (2009) Effect of hyaluronic acid in symptomatic hip osteoarthritis: a multicenter, randomized, placebo-controlled trial. Arthr Rheum 60(3):824–830
Moskowitz RW, Blaine TA (2005) An overview of treatment options for persistent shoulder pain. Am J Orthop 34(12 Suppl):10–15
Silverstein E, Leger R, Shea KP (2007) The use of intra-articular hylan G-F 20 in the treatment of symptomatic osteoarthritis of the shoulder: a preliminary study. Am J Sports Med 35(6):979–985
Shibata Y, Midorikawa K, Emoto G, Naito M (2001) Clinical evaluation of sodium hyaluronate for the treatment of patients with rotator cuff tear. J Shoulder Elbow Surg 10(3):209–216
Blaine T, Moskowitz R, Udell J, Skyhar M, Levin R, Friedlander J et al (2008) Treatment of persistent shoulder pain with sodium hyaluronate: a randomized, controlled trial. A multicenter study. J Bone Joint Surg Am 90(5):970–979
Itokazu M, Matsunaga T (1995) Clinical evaluation of high-molecular-weight sodium hyaluronate for the treatment of patients with periarthritis of the shoulder. Clin Ther 17(5):946–955
Leardini G, Perbellini A, Franceschini M, Mattara L (1988) Intra-articular injections of hyaluronic acid in the treatment of painful shoulder. Clin Ther 10(5):521–526
Calis M, Demir H, Ulker S, Kirnap M, Duygulu F, Calis HT (2006) Is intraarticular sodium hyaluronate injection an alternative treatment in patients with adhesive capsulitis? Rheumatol Int 26(6):536–540
Tamai K, Mashitori H, Ohno W, Hamada J, Sakai H, Saotome K (2004) Synovial response to intraarticular injections of hyaluronate in frozen shoulder: a quantitative assessment with dynamic magnetic resonance imaging. J Orthop Sci 9(3):230–234
Lee HJ, Lim KB, Kim DY, Lee KT (2009) Randomized controlled trial for efficacy of intra-articular injection for adhesive capsulitis: ultrasonography-guided versus blind technique. Arch Phys Med Rehabil 90(12):1997–2002
Karatosun V, Unver B, Ozden A, Ozay Z, Gunal I (2008) Intra-articular hyaluronic acid compared to exercise therapy in osteoarthritis of the ankle. A prospective randomized trial with long-term follow-up. Clin Exp Rheumatol 26(2):288–294
Cohen MM, Altman RD, Hollstrom R, Hollstrom C, Sun C, Gipson B (2008) Safety and efficacy of intra-articular sodium hyaluronate (Hyalgan) in a randomized, double-blind study for osteoarthritis of the ankle. Foot Ankle Int 29(7):657–663
Salk RS, Chang TJ, D’Costa WF, Soomekh DJ, Grogan KA (2006) Sodium hyaluronate in the treatment of osteoarthritis of the ankle: a controlled, randomized, double-blind pilot study. J Bone Joint Surg Am 88(2):295–302
Sun SF, Chou YJ, Hsu CW, Hwang CW, Hsu PT, Wang JL et al (2006) Efficacy of intra-articular hyaluronic acid in patients with osteoarthritis of the ankle: a prospective study. Osteoarthr Cartil 14(9):867–874
Filkova M, Senolt L, Braun M, Hulejova H, Pavelkova A, Sleglova O, et al. (2009) Serum hyaluronic acid as a potential marker with a predictive value for further radiographic progression of hand osteoarthritis. Osteoarthritis Cartilage
Schumacher HR, Meador R, Sieck M, Mohammed Y (2004) Pilot Investigation of Hyaluronate Injections for First Metacarpal-Carpal (MC-C) Osteoarthritis. J Clin Rheumatol 10(2):59–62
Stahl S, Karsh-Zafrir I, Ratzon N, Rosenberg N (2005) Comparison of intraarticular injection of depot corticosteroid and hyaluronic acid for treatment of degenerative trapeziometacarpal joints. J Clin Rheumatol 11(6):299–302
Bahadir C, Onal B, Dayan VY, Gurer N (2009) Comparison of therapeutic effects of sodium hyaluronate and corticosteroid injections on trapeziometacarpal joint osteoarthritis. Clin Rheumatol 28(5):529–533
Fuchs S, Monikes R, Wohlmeiner A, Heyse T (2006) Intra-articular hyaluronic acid compared with corticoid injections for the treatment of rhizarthrosis. Osteoarthr Cartil 14(1):82–88
van Brakel RW, Eygendaal D (2006) Intra-articular injection of hyaluronic acid is not effective for the treatment of post-traumatic osteoarthritis of the elbow. Arthroscopy 22(11):1199–1203
Bjornland T, Gjaerum AA, Moystad A (2007) Osteoarthritis of the temporomandibular joint: an evaluation of the effects and complications of corticosteroid injection compared with injection with sodium hyaluronate. J Oral Rehabil 34(8):583–589
Arrich J, Piribauer F, Mad P, Schmid D, Klaushofer K, Mullner M (2005) Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis. CMAJ 172(8):1039–1043
Divine JG, Zazulak BT, Hewett TE (2007) Viscosupplementation for knee osteoarthritis: a systematic review. Clin Orthop Relat Res 455:113–122
Wang CT, Lin J, Chang CJ, Lin YT, Hou SM (2004) Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. J Bone Joint Surg Am 86-A(3):538–545
Modawal A, Ferrer M, Choi HK, Castle JA (2005) Hyaluronic acid injections relieve knee pain. J Fam Pract 54(9):758–767
Bellamy N (2006) Hyaluronic acid and knee osteoarthritis. J Fam Pract 55(11):967–968
Salini V, De Amicis D, Abate M, Natale MA, Di Iorio A (2009) Ultrasound-guided hyaluronic acid injection in carpometacarpal osteoarthritis: short-term results. Int J Immunopathol Pharmacol 22(2):455–460
Clerc D (2006) Sinovial® dans la gonarthrose: une étude en situation réelle d’utilisation chez 408 patients. Rhumatos 3(Suppl. 1):1–4
Pavelka K (2010) Efficacy evaluation of a highly purified intra-articular hyaluronic acid obtained by bacterial fermentation vs. hylan G-F20 in the treatment of symptomatic knee osteoarthritis: a double-blind, controlled, randomized, parallel-group non-inferiority study [abstract]. Osteoporos Int 21(Suppl 1):S387
Wei N, Delauter SK, Sheila JB (2002) Arthroscopic debridement and visco-supplementation: a minimally invasive treatment for symptomatic osteoarthritis involving the base of the thumb. J Clin Rheumatol 8(3):125–129
Lohmander LS, Dalen N, Englund G, Hamalainen M, Jensen EM, Karlsson K et al (1996) Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomised, double blind, placebo controlled multicentre trial. Hyaluronan Multicentre Trial Group. Ann Rheum Dis 55(7):424–431
Puhl W, Bernau A, Greiling H, Kopcke W, Pforringer W, Steck KJ et al (1993) Intra-articular sodium hyaluronate in osteoarthritis of the knee: a multicenter, double-blind study. Osteoarthr Cartil 1(4):233–241
Wu JJ, Shih LY, Hsu HC, Chen TH (1997) The double-blind test of sodium hyaluronate (ARTZ) on osteoarthritis knee. Zhonghua Yi Xue Za Zhi (Taipei) 59(2):99–106
Acknowledgments
We thank Nila Bhana of inScience Communications, a Wolters Kluwer business, who provided medical writing support funded by IBSA. The authors have no conflicts of interest that are directly relevant to the content of this review.
Author information
Authors and Affiliations
Corresponding author
Additional information
An erratum to this article can be found at http://dx.doi.org/10.1007/s00296-011-1919-6
Rights and permissions
About this article
Cite this article
Gigante, A., Callegari, L. The role of intra-articular hyaluronan (Sinovial®) in the treatment of osteoarthritis. Rheumatol Int 31, 427–444 (2011). https://doi.org/10.1007/s00296-010-1660-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-010-1660-6